Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Ryan C Lynch

TitleAffiliate
InstitutionUniversity of Colorado Boulder
DepartmentEcology & Evolutionary Biology

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lynch RC, Gratzinger D, Advani RH. Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification. Curr Treat Options Oncol. 2017 Oct; 18(10):60. PMID: 28861885.
      View in: PubMed
    2. Lynch RC, Advani RH. Dramatic Response with Single-Agent Ibrutinib in Multiply Relapsed Marginal Zone Lymphoma with MYD88L265P Mutation. Case Rep Oncol. 2017 Sep-Dec; 10(3):813-818. PMID: 29070995.
      View in: PubMed
    3. Lynch RC, Gratzinger D, Advani RH. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification. Curr Treat Options Oncol. 2017 Jul; 18(7):45. PMID: 28670664.
      View in: PubMed
    4. Leff JW, Lynch RC, Kane NC, Fierer N. Plant domestication and the assembly of bacterial and fungal communities associated with strains of the common sunflower, Helianthus annuus. New Phytol. 2017 Apr; 214(1):412-423. PMID: 27879004.
      View in: PubMed
    5. McKernan K, Spangler J, Helbert Y, Lynch RC, Devitt-Lee A, Zhang L, Orphe W, Warner J, Foss T, Hudalla CJ, Silva M, Smith DR. Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests. F1000Res. 2016; 5:2471. PMID: 27853518.
      View in: PubMed
    6. Xiao DY, Luo S, O'Brian K, Ganti A, Riedell P, Sanfilippo KM, Lynch RC, Liu W, Carson KR. Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy. Am J Hematol. 2016 Oct; 91(10):1002-7. PMID: 27356783.
      View in: PubMed
    7. Xiao DY, Luo S, O'Brian K, Sanfilippo KM, Ganti A, Riedell P, Lynch RC, Liu W, Kahl BS, Cashen AF, Fehniger TA, Carson KR. Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans. J Natl Cancer Inst. 2016 Nov; 108(11). PMID: 27381623.
      View in: PubMed
    8. Lynch RC, Advani RH. Risk-Adapted Treatment of Advanced Hodgkin Lymphoma With PET-CT. Am Soc Clin Oncol Educ Book. 2016; 35:e376-85. PMID: 27249744.
      View in: PubMed
    9. O'Brian K, Luo S, Ganti A, Riedell P, Lynch RC, Roop R, Sanfilippo KM, Liu W, Colditz GA, Carson KR. Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy. Leuk Lymphoma. 2015 Jul 25; 1-7. PMID: 26085202.
      View in: PubMed
    10. Lynch RC, Medeiros BC. Chemotherapy options for previously untreated acute myeloid leukemia. Expert Opin Pharmacother. 2015; 16(14):2149-62. PMID: 26364895.
      View in: PubMed
    11. Lynch RC, Darcy JL, Kane NC, Nemergut DR, Schmidt SK. Metagenomic evidence for metabolism of trace atmospheric gases by high-elevation desert Actinobacteria. Front Microbiol. 2014; 5:698. PMID: 25566214; PMCID: PMC4269115.
    12. Knelman JE, Schmidt SK, Lynch RC, Darcy JL, Castle SC, Cleveland CC, Nemergut DR. Nutrient addition dramatically accelerates microbial community succession. PLoS One. 2014; 9(7):e102609. PMID: 25050551; PMCID: PMC4106831.
    13. Lynch RC, Zelenetz AD, Armitage JO, Carson KR. Surveillance imaging for lymphoma: pros and cons. Am Soc Clin Oncol Educ Book. 2014; e388-95. PMID: 24857129.
      View in: PubMed
    14. Nemergut DR, Schmidt SK, Fukami T, O'Neill SP, Bilinski TM, Stanish LF, Knelman JE, Darcy JL, Lynch RC, Wickey P, Ferrenberg S. Patterns and processes of microbial community assembly. Microbiol Mol Biol Rev. 2013 Sep; 77(3):342-56. PMID: 24006468; PMCID: PMC3811611.
    15. Darcy JL, Lynch RC, King AJ, Robeson MS, Schmidt SK. Global distribution of Polaromonas phylotypes--evidence for a highly successful dispersal capacity. PLoS One. 2011; 6(8):e23742. PMID: 21897856; PMCID: PMC3163589.
    16. Grillo J, DelloRusso C, Lynch RC, Folkman J, Zaslavsky A. Regulation of the angiogenesis inhibitor thrombospondin-1 by the breast cancer susceptibility gene-1 (BRCA1). Breast J. 2011 Jul-Aug; 17(4):434-5. PMID: 21679271.
      View in: PubMed
    17. King AJ, Freeman KR, McCormick KF, Lynch RC, Lozupone C, Knight R, Schmidt SK. Biogeography and habitat modelling of high-alpine bacteria. Nat Commun. 2010 Aug 10; 1:53. PMID: 20975720.
      View in: PubMed
    18. Zaslavsky A, Baek KH, Lynch RC, Short S, Grillo J, Folkman J, Italiano JE, Ryeom S. Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood. 2010 Jun 03; 115(22):4605-13. PMID: 20086246; PMCID: PMC2881490.
    19. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature. 2009 Jun 25; 459(7250):1126-30. PMID: 19458618; PMCID: PMC2724004.
    20. Lim R, Morrill JM, Lynch RC, Reed KL, Gower AC, Leeman SE, Stucchi AF, Becker JM. Practical limitations of bioresorbable membranes in the prevention of intra-abdominal adhesions. J Gastrointest Surg. 2009 Jan; 13(1):35-41; discussion 41-2. PMID: 18854958.
      View in: PubMed
    21. Ryeom S, Baek KH, Rioth MJ, Lynch RC, Zaslavsky A, Birsner A, Yoon SS, McKeon F. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell. 2008 May; 13(5):420-31. PMID: 18455125.
      View in: PubMed
    22. Johannessen CM, Johnson BW, Williams SM, Chan AW, Reczek EE, Lynch RC, Rioth MJ, McClatchey A, Ryeom S, Cichowski K. TORC1 is essential for NF1-associated malignancies. Curr Biol. 2008 Jan 08; 18(1):56-62. PMID: 18164202.
      View in: PubMed
    23. Giuriato S, Ryeom S, Fan AC, Bachireddy P, Lynch RC, Rioth MJ, van Riggelen J, Kopelman AM, Passegué E, Tang F, Folkman J, Felsher DW. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. Proc Natl Acad Sci U S A. 2006 Oct 31; 103(44):16266-71. PMID: 17056717; PMCID: PMC1637571.
    24. Shen Y, Iqbal J, Xiao L, Lynch RC, Rosenwald A, Staudt LM, Sherman S, Dybkaer K, Zhou G, Eudy JD, Delabie J, McKeithan TW, Chan WC. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol. 2004 Sep 15; 5:20. PMID: 15369600; PMCID: PMC535350.
    Lynch's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)